Clinical Trial Update: Time Based Strategy to Reduce Clopidogrel Associated Bleeding Related to Coronary Artery Bypass Graft (CABG) [NA]

View source ↗

Summary

A clinical trial update evaluating a time-based strategy to reduce bleeding related to clopidogrel in patients undergoing coronary artery bypass graft surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: LifeBridge Health | Conditions: Coronary Artery Disease | NA | Status: UNKNOWN